Association between height and circulating CD34-positive cells taken into account for the influence of enhanced production among elderly Japanese men: a cross-sectional study.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
29 01 2019
Historique:
received: 01 11 2018
accepted: 05 01 2019
pubmed: 30 1 2019
medline: 4 4 2020
entrez: 30 1 2019
Statut: ppublish

Résumé

Recent studies have revealed an inverse association between height and cardiovascular disease and that endothelial progenitor cells (CD34-positive cells) contribute to vascular maintenance, which is associated with cardiovascular disease. However, evidence of the association between height and CD34-positive positive cells among elderly participants is limited. To assess this association, we conducted a cross-sectional study of 231 elderly Japanese men aged 65-69. Since enhanced production of circulating CD34-positive cells in response to endothelial injury might act have a strong confounding effect on the association between height and circulating CD34-positive cells, the median value for the levels of these cells (0.93 cells/μL) was used to stratify the participants. Multivariable linear regression analysis demonstrated that height was significantly positively associated with circulating CD34-positive cells for those participants with low levels of circulating CD34-positive cells (n=114) but not for those with higher levels (n=117), with a multi-adjusted standardized parameter estimate (β) of 0.27 (p=0.008) for low and 0.11 (0.275) for higher circulating CD34-positive cell levels. The positive association is limited to participants with relatively low circulating CD34-positive cell levels, whose productivity of these cells is not activated. Our findings indicate that height is an indicator of vascular maintenance capability in elderly Japanese men.

Identifiants

pubmed: 30695751
pii: 101768
doi: 10.18632/aging.101768
pmc: PMC6366994
doi:

Substances chimiques

Antigens, CD34 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-672

Références

Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Oncotarget. 2016 Jul 19;7(29):44919-44926
pubmed: 27374094
FASEB J. 2006 Dec;20(14):2559-61
pubmed: 17077283
Clin Orthop Relat Res. 2007 Dec;465:202-7
pubmed: 17891036
Ther Clin Risk Manag. 2015 Mar 06;11:381-91
pubmed: 25834453
Circulation. 2008 Jan 15;117(2):206-15
pubmed: 18086932
Int J Epidemiol. 2018 Feb 1;47(1):289-298
pubmed: 29025084
Geriatr Gerontol Int. 2017 Dec;17(12):2586-2592
pubmed: 28581690
Atherosclerosis. 2015 Nov;243(1):71-6
pubmed: 26363435
Aging (Albany NY). 2016 Oct 4;8(10):2407-2413
pubmed: 27705902
Blood. 1998 Jul 15;92(2):362-7
pubmed: 9657732
Environ Health Prev Med. 2018 May 3;23(1):16
pubmed: 29724162
Oncotarget. 2017 Dec 23;9(8):7749-7757
pubmed: 29487687
Environ Health Prev Med. 2017 Nov 21;22(1):77
pubmed: 29165175
Nat Med. 1999 Apr;5(4):434-8
pubmed: 10202935
Hematology Am Soc Hematol Educ Program. 2005;:528-32
pubmed: 16304431
J Hematother. 1996 Jun;5(3):213-26
pubmed: 8817388
Mech Ageing Dev. 2010 Nov-Dec;131(11-12):718-22
pubmed: 21035480
Science. 1997 Feb 14;275(5302):964-7
pubmed: 9020076
J Exp Med. 2006 Apr 17;203(4):1055-65
pubmed: 16606664
Clin Med Cardiol. 2009 May 27;3:53-60
pubmed: 20407620
Med Sci Monit. 2004 Apr;10(4):RA63-76
pubmed: 15039658
J Physiol Anthropol. 2017 Jun 15;36(1):26
pubmed: 28619079
Aging Male. 2015 Jun;18(2):100-5
pubmed: 25055346
Environ Health Prev Med. 2016 Sep;21(5):361-367
pubmed: 27164867
Sultan Qaboos Univ Med J. 2015 Aug;15(3):e344-50
pubmed: 26357554
Acta Paediatr. 2012 Mar;101(3):e115-21
pubmed: 22026536
Geriatr Gerontol Int. 2017 Oct;17(10):1729-1736
pubmed: 27562673
J Physiol Anthropol. 2016 Dec 6;35(1):29
pubmed: 27919279
Cell. 2000 Jul 21;102(2):199-209
pubmed: 10943840
Atherosclerosis. 2017 Apr;259:26-31
pubmed: 28282559
Eur J Epidemiol. 2011 Jan;26(1):13-21
pubmed: 20953671
Clin Hemorheol Microcirc. 1999;21(3-4):365-74
pubmed: 10711772
J Physiol Anthropol. 2013 Nov 01;32:19
pubmed: 24180493
J Stroke Cerebrovasc Dis. 2014 Apr;23(4):667-74
pubmed: 23871699
Proc (Bayl Univ Med Cent). 2011 Apr;24(2):115-8
pubmed: 21566758

Auteurs

Yuji Shimizu (Y)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Cardiovascular Disease Prevention, Osaka Center for Cancer and Cardiovascular Disease Prevention, Osaka, Japan.

Hirotomo Yamanashi (H)

Department of General Medicine, Nagasaki University Hospital, Nagasaki, Japan.

Yuko Noguchi (Y)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Jun Koyamatsu (J)

Department of Island and Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Mako Nagayoshi (M)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Kairi Kiyoura (K)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Shoichi Fukui (S)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Mami Tamai (M)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagsaki, Japan.

Shin-Ya Kawashiri (SY)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Kazuhiko Arima (K)

Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Takahiro Maeda (T)

Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of General Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Department of Island and Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH